1,353
Views
5
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Repurposing of atorvastatin emulsomes as a topical antifungal agent

ORCID Icon, , & ORCID Icon
Pages 3414-3431 | Received 27 Sep 2022, Accepted 15 Nov 2022, Published online: 25 Nov 2022

References

  • Abdellatif MM, Khalil IAF, Khalil MAF. (2017). Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: in-vitro, ex-vivo and in-vivo evaluation. Int J Pharm 527:1–11.
  • Abo El-Enin HA, Mostafa RE, Ahmed MF, et al. (2022). Assessment of nasal-brain-targeting efficiency of new developed mucoadhesive emulsomes encapsulating an anti-migraine drug for effective treatment of one of the major psychiatric disorders symptoms. Pharmaceutics 14:410.
  • Abootorabi S, Akbari J, Saeedi M, et al. (2022). Atorvastatin entrapped noisome (atrosome): green preparation approach for wound healing. AAPS PharmSciTech 23:81.
  • Aburahma MH, Badr-Eldin SM. (2014). Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin Drug Deliv 11:1865–83.
  • Aldawsari HM, Ahmed OAA, Alhakamy NA, et al. (2021). Lipidic nano-sized emulsomes potentiates the cytotoxic and apoptotic effects of raloxifene hydrochloride in MCF-7 human breast cancer cells: factorial analysis and in vitro anti-tumor activity assessment. Pharmaceutics 13:783.
  • Alhakamy NA, Badr-Eldin SM, Ahmed O, et al. (2020). Piceatannol-loaded emulsomes exhibit enhanced cytostatic and apoptotic activities in colon cancer cells. Antioxidants 9:419.
  • Alvarez-Román R, Naik A, Kalia Y, et al. (2004). Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm 58:301–16.
  • Alyousef AA. (2021). Antifungal activity and mechanism of action of different parts of myrtus communis growing in Saudi Arabia against Candida Spp. J Nanomater 2021:1–10.
  • Bolat ZB, Islek Z, Demir BN, et al. (2020). Curcumin- and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model. Front Bioeng Biotechnol 8:50.
  • Cooper DL, Harirforoosh S. (2014). Effect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticles. PLoS One 9:e113558.
  • Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–33.
  • da Silva EP, Pereira MAV, de Barros Lima IP, et al. (2016). Compatibility study between atorvastatin and excipients using DSC and FTIR. J Therm Anal Calorim 123:933–9.
  • Danaei M, Dehghankhold M, Ataei S, et al. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10:57.
  • de Oliveira Santos GC, Vasconcelos CC, Lopes AJO, et al. (2018). Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents. Front Microbiol 9:1351.
  • Dubey S, Vyas SP. (2021). Emulsomes for lipophilic anticancer drug delivery: development, optimization and in vitro drug release kinetic study. Int J App Pharm 13:114–21.
  • El-Zaafarany GM, Soliman ME, Mansour S, Awad GAS. (2016). Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: in vitro and rat in vivo studies. Int J Pharm 503:127–40.
  • Elakkad YE, Younis MK, Allam RM, et al. (2021). Tenoxicam loaded hyalcubosomes for osteoarthritis. Int J Pharm 601:120483.
  • Elbaz NM, Khalil IA, Abd-Rabou AA, El-Sherbiny IM. (2016). Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. Int J Biol Macromol 92:254–69.
  • Fahmy UA, Aldawsari HM, Badr-Eldin SM, et al. (2020). The encapsulation of febuxostat into emulsomes strongly enhances the cytotoxic potential of the drug on HCT 116 colon cancer cells. Pharmaceutics 12:956.
  • Ghanem HA, Nasr AM, Hassan TH, et al. (2021). Comprehensive study of atorvastatin nanostructured lipid carriers through multivariate conceptualization and optimization. Pharmaceutics 13:178.
  • Ghasemiyeh P, Mohammadi-Samani S. (2020). Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages. Drug Des Devel Ther 14:3271–89.
  • Hughes J, Rees S, Kalindjian S, Philpott K. (2011). Principles of early drug discovery. Br J Pharmacol 162:1239–49.
  • Hussain A, Singh VK, Singh OP, et al. (2016). Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B. Drug Deliv 23:3101–10.
  • Jagdale SC, Patil SA, Kuchekar BS, Chabukswar AR. (2011). Preparation and characterization of metformin hydrochloride − Compritol 888 ATO solid dispersion. J Young Pharm 3:197–204.
  • Jiang W, Hu J-W, He X-R, et al. (2021). Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res 40:241.
  • Kassem AA, Abd El-Alim SH, Asfour MH. (2017). Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: formulation development, in vitro and in vivo evaluation of skin deposition. Int J Pharm 517:256–68.
  • Kauffman CA, Sobel JD, Pappas PG, Dismukes WE. 2011. Essentials of clinical mycology. 2nd ed. New York, NY: Springer.
  • Kim JH, Cheng LW, Chan KL, et al. (2020). Antifungal drug repurposing. Antibiotics 9:812.
  • Ko HHT, Lareu RR, Dix BR, Hughes JD. (2018). In vitro antibacterial effects of statins against bacterial pathogens causing skin infections. Eur J Clin Microbiol Infect Dis 37:1125–35.
  • Kumar R, Seth N, Hari kumar SL. (2013). Emulsomes: an emerging vesicular drug delivery system. J Drug Deliv Ther 3:133–42.
  • Mahmoud DE, Faraag AHI, El-Wafa WM. (2021). In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans. World J Microbiol Biotechnol 37:191.
  • Mahmoud MO, Aboud HM, Hassan AH, et al. (2017). Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. J Control Release 254:10–22.
  • Mendyk A, Jachowicz R, Fijorek K, et al. (2012). KinetDS: an open source software for dissolution test data analysis. Dissolution Technol 19:6–11.
  • Miró-Canturri A, Ayerbe-Algaba R, Smani Y. (2019). Drug repurposing for the treatment of bacterial and fungal infections. Front Microbiol 10:41.
  • Mosallam S, Ragaie MH, Moftah NH, et al. (2021). Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: in vitro characterization, in vivo assessment and exploratory clinical experimentation. Int J Nanomed 16:119–32.
  • Nasr Esfahani A, Golestannejad Z, Khozeimeh F, et al. (2019). Antifungal effect of atorvastatin against Candida species in comparison to fluconazole and nystatin. Med Pharm Rep 92:368–73.
  • Nasr M, Ghorab MK, Abdelazem A. (2015). In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B 5:79–88.
  • Paliwal R, Paliwal SR, Mishra N, et al. (2009). Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm 380:181–8.
  • Peyclit L, Yousfi H, Rolain J-M, Bittar F. (2021). Drug repurposing in medical mycology: identification of compounds as potential antifungals to overcome the emergence of multidrug-resistant fungi. Pharmaceuticals 14:488.
  • Pushpakom S, Iorio F, Eyers PA, et al. (2019). Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41–58.
  • Putri AD, Chen P-S, Su Y-L, et al. (2021). Optimization and development of selective histone deacetylase inhibitor (MPT0B291)-loaded albumin nanoparticles for anticancer therapy. Pharmaceutics 13:1728.
  • Rayens E, Norris KA. (2022). Prevalence and healthcare burden of fungal infections in the United States, 2018. Open Forum Infect Dis 9:ofab593.
  • Raza K, Katare OP, Setia A, et al. (2013). Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes. J Microencapsul 30:225–36.
  • Rodríguez-Tudela JL, Barchiesi F, Bille J, et al. (2003). Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect 9:i–viii.
  • Sawant D, Dandagi PM, Gadad AP. (2016). Formulation and evaluation of sparfloxacin emulsomes-loaded thermosensitive in situ gel for ophthalmic delivery. J Sol-Gel Sci Technol 77:654–65.
  • Senyiğit ZA, Karavana SY, Eraç B, et al. (2014). Evaluation of chitosan based vaginal bioadhesive gel formulations for antifungal drugs. Acta Pharm 64:139–56.
  • Shahraeini SS, Akbari J, Saeedi, et al. (2020). Atorvastatin solid lipid nanoparticles as a promising approach for dermal delivery and an anti-inflammatory agent. AAPS PharmSciTech 21:263.
  • Shamma RN, Aburahma MH. (2014). Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia. Int J Nanomed 9:5449–60.
  • Shamma RN, Sayed S, Sabry NA, El-Samanoudy SI. (2019). Enhanced skin targeting of retinoic acid spanlastics: in vitro characterization and clinical evaluation in acne patients. J Liposome Res 29:283–90.
  • Silva R, Ferreira H, Little C, Cavaco-Paulo A. (2010). Effect of ultrasound parameters for unilamellar liposome preparation. Ultrason Sonochem 17:628–32.
  • Sinico C, Fadda AM. (2009). Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 6:813–25.
  • Sirtori CR. (2014). The pharmacology of statins. Pharmacol Res 88:3–11.
  • Suvarna SK, Layton C, Bancroft JD. 2012. Bancroft’s theory and practice of histological techniques. 7th ed. Netherlands, Amsterdam: Elsevier Health Sciences.
  • Tavakkoli A, Johnston TP, Sahebkar A. (2020). Antifungal effects of statins. Pharmacol Ther 208:107483.
  • Ucisik M, Sleytr U, Schuster B. (2015). Emulsomes meet S-layer proteins: an emerging targeted drug delivery system. Curr Pharm Biotechnol 16:392–405.
  • Vyas SP, Subhedar R, Jain S. (2006). Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. J Pharm Pharmacol 58:321–6.
  • Watanabe T, Hamada K, Tategaki A, et al. (2009). Oral administration of lactic acid bacteria isolated from traditional South Asian fermented milk “dahi” inhibits the development of atopic dermatitis in NC/Nga mice. J Nutr Sci Vitaminol (Tokyo) 55:271–8.
  • Zhang L, Li, X, Zhu S, et al. (2020). Dermal targeting delivery of terbinafine hydrochloride using novel multi-ethosomes: a new approach to fungal infection treatment. Coatings 10:304.
  • Zhang Y, Huo M, Zhou J, et al. (2010). DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12:263–71.
  • Zhao GD, Sun R, Ni SL, Xia Q. (2015). Development and characterisation of a novel chitosan-coated antioxidant liposome containing both coenzyme Q10 and alpha-lipoic acid. J Microencapsul 32:157–65.
  • Zhou X, Chen Z. (2015). Preparation and performance evaluation of emulsomes as a drug delivery system for silybin. Arch Pharm Res 38:2193–200.